Association between asthma, asthma symptoms and C-reactive protein in US adults: Data from the national health and nutrition examination survey, 1999-2002

Respirology

Volumn 12, Issue 5, 2007, Pages 675-682

  Arif, Ahmed A ^a,c   Delclos, George L ^b   Colmer Hamood, Jane ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; CRP; Epidemiology; NHANES; Respiratory sound

Indexed keywords

C REACTIVE PROTEIN; MARKER;

ADULT; AGED; ARTICLE; ASTHMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NUTRITION; OUTCOME VARIABLE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SYMPTOM; WHEEZING;

ADULT; ASTHMA; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PREVALENCE; RESPIRATORY SOUNDS; UNITED STATES;

EID: 34548691638     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2007.01122.x     Document Type: Article

References (19)

1. Janeway CA, Travers P, Walport M, Shlomchik M. Innate immunity. In : Janeway CA, Travers P, Walport M, Shlomchik M (eds). Immunobiology: The Immune System in Health and Disease. Garland Publishing, New York, 2001 35 88.
2. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J. Clin. Invest. 2003 111 : 1805 12.
3. Black S, Kushner I, Samols D. C-reactive protein. J. Biol. Chem. 2004 47 : 48487 90.
4. Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005 60 : 451 4.
5. Jousilahti P, Salomaa V, Kakala K, Rasi V, Vahtera E et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann. Allergy Asthma Immunol. 2002 89 : 381 5.
6. Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H et al. High sensitivity C-reactive protein in asthma. Eur. Respir. J. 2006 27 : 908 12.
7. Malik S, Wong ND, Franklin S, Pio J, Fairchild C et al. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 2005 28 : 690 3.
8. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 2002 347 : 1557 65.
9. Dessein PH, Joffe BI, Stanwix AE. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. J. Rheumatol. 2004 31 : 1095 7.
10. National Center for Health Statistics. National Health and Nutrition Examination Survey. 9 December 2005. [Accessed 25 September 2005.] Available from URL: http://www.cdc.gov/nchs/nhanes.htm
11. National Heart, Lung and Blood Institute National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, Bethesda, MD, 1997. Publi. No. 97-4051.
12. National Center for Health Statistics. National Health and Nutrition Examination Survey. Anthropometry Procedures Manual. December 2006. [Accessed 5 July 2000.] Available from URL: http://www.cdc.gov/nchs/data/nhanes/bm.pdf
13. Savykoski T, Harju T, Paldanius M, Kuitunen H, Bloigu A et al. Chlamydia pneumoniae infection and inflammation in adults with asthma. Respiration 2004 71 : 120 5.
14. Ford ES. Asthma, body mass ratio, and C-reactive protein among US adults. J. Asthma 2003 40 : 733 9.
15. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur. Heart J. 2005 26 : 1765 73.
16. Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ et al. Biomarkers of vascular disease linking inflammation to endothelial activation: part II. Circulation 2003 108 : 2041 8.
17. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 : 1135 43.
18. Arif AA, Delclos GL, Lee ES, Tortolero SR, Whitehead LW. Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data. Eur. Respir. J. 2003 21 : 827 33.
19. Colombo C, Costantini D, Rocchi A, Cariani L, Garlaschi ML et al. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Pediatr. Pulmonol. 2005 40 : 15 21.